chr12-112578749-C-T
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001347952.2(RPH3A):c.-140+3430C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.148 in 152,120 control chromosomes in the GnomAD database, including 3,052 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001347952.2 intron
Scores
Clinical Significance
Conservation
Publications
- neurodevelopmental disorderInheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, PanelApp Australia
- complex neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- congenital myasthenic syndromeInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001347952.2. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.148 AC: 22477AN: 152000Hom.: 3059 Cov.: 32 show subpopulations
GnomAD4 genome AF: 0.148 AC: 22477AN: 152120Hom.: 3052 Cov.: 32 AF XY: 0.153 AC XY: 11367AN XY: 74378 show subpopulations
Age Distribution
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at